MediPal Holdings Corporation (MEPDF)

OTCMKTS · Delayed Price · Currency is USD
19.00
0.00 (0.00%)
At close: Feb 4, 2026
Market Cap3.93B +26.5%
Revenue (ttm)24.08B +3.4%
Net Income264.40M -16.1%
EPS1.28 -15.2%
Shares Outn/a
PE Ratio14.85
Forward PEn/a
Dividend0.42 (2.23%)
Ex-Dividend DateMar 30, 2026
Volume200
Average Volume1,114
Open19.00
Previous Close19.00
Day's Range19.00 - 19.00
52-Week Range14.75 - 19.00
Beta-0.10
RSI56.67
Earnings DateFeb 9, 2026

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product... [Read more]

Sector Healthcare
Founded 1898
Employees 13,061
Stock Exchange OTCMKTS
Ticker Symbol MEPDF
Full Company Profile

Financial Performance

In fiscal year 2025, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.

Financial numbers in JPY Financial Statements